Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 26 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing that it received final approval from the USFDA for Bisoprolol Fumarate Tablets. These tablets are used to treat high blood pressure and will be manufactured in Ahmedabad, India. The approval allows Zydus to market the tablets in two dosages, and they will be distributed by Viona Pharmaceuticals Inc. The press release highlights that Bisoprolol Fumarate Tablets had significant annual sales in the United States according to market data.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases